Articles, guides, and regulatory updates from our community.
A 2026 critical review examines peptide use in competitive and recreational sport, highlighting limited clinical evidence and emerging health risks. Read the findings.
By Peptide Association Research Team
New research identifies a novel chemical impurity in compounded tirzepatide/B12 products. Learn what this means for patient safety and informed treatment decisions.
By Peptide Association Research Team
New research examines safety profiles of approved and unapproved peptide therapies for sports medicine, revealing gaps in human safety data for popular compounds.
By Peptide Association Research Team
Comprehensive study examines approved and unapproved peptides for musculoskeletal injuries. Learn about safety profiles and regulatory status.
By Peptide Association Research Team
New research examines safety and efficacy of approved vs. unapproved peptide therapies for musculoskeletal injuries and athletic performance.
By Peptide Association Research Team
New research examines safety and efficacy of approved vs unapproved peptide therapies for injury recovery and performance enhancement.
By Peptide Association Research Team